N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-5-methylpyrazine-2-carboxamide-D11; N-[2-[4[[[(Cyclohexylamino-d11)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methylpyrazinecarboxamide; 1-(Cyclohexyl-d11)-3-[[p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl]sulfonyl]urea; Aldiab-d11; Digrin-d11; Dipazide-d11; Glibenese-d11; Glibetin-d11; Glican-d11; Glidiab-d11; Glipid-d11; Glipizid-d11; Gluco-Rite-d11; Glucolip-d11; Glucotrol-d11; Glucozide-d11; Glupitel-d11; Glupizid-d11; Napizide-d11; Ozidia-d11; Semiglynase-d11; Sucrazide-d11; TK 1320-d11
Glipizide-d11 is a fully characterized chemical compound used as a reference standard of API Glipizide. The standard offered is compliant with regulatory guidelines. Glipizide-d11 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1189426-07-0
Related products
Des(5-methylpyrazinecarbonyl) Glipizide HCl
M.F.
M.W. 325.43. 36.46
CAT# AR-G01723
CAS# 1428553-61-0 (HCl Salt)